Page 716 - ACCCN's Critical Care Nursing
P. 716

Paediatric Considerations in Critical Care  693

             perfusion (V/Q) mismatch due to lower airway obstruc-  unresponsive to inhaled bronchodilators and steroids. It
             tion,  in  addition  to  hypoventilation,  hypercarbia,  and   is a bronchodilator, improving diaphragmatic contractil-
             pulmonary vasoconstriction related to acidosis. Hypoxae-  ity  and  a  central  respiratory  stimulant.  However,  the
             mia can result in further bronchoconstriction, hypoten-  narrow therapeutic window and side effects of induced
             sion, systemically-reduced oxygen availability, increased   nausea  and/or  vomiting  represent  a  non-negligible  risk
             myocardial oxygen consumption and neurological symp-  of complication, thus its use should be limited to manag-
             toms such as agitation, confusion or decreased level of   ing asthma not responsive to other agents. 138
             consciousness. Bronchodilators may worsen hypoxaemia   Ventilation may be required when there is profound hy-
             through  worsening  V/Q  mismatch  or  bronchoconstric-  poxaemia,  severe  muscle  fatigue  or  decreased  level  of
             tion, due to the hyperosmolarity of the nebulised solu-  consciousness. 130,139   However,  as  asthmatic  children  are
             tion. In addition, rapid changes to the compliance of the   at higher risk of complications such as barotrauma and
             airways together with hyperexpanded lungs may result in   air  trapping,  there  is  a  higher  risk  of  death  associated
             airway collapse.
                                                                  with ventilation in this group of patients. Non-invasive
             Oxygen  delivery  is  achieved  by  high-flow  oxygen  mask   positive  pressure  ventilation  (NPPV)  is  the  first  choice,
             with  a  reservoir  bag.  All  nebuliser  therapy  should  be   with some evidence that it rapidly corrects gas exchange
             oxygen-driven.  However,  if  hypoxaemia  persists  despite   abnormalities  and  assists  with  respiratory  muscle
             maximal bronchodilator therapy and oxygen administra-  fatigue. 140-142   The  contraindications  for  NPPV  include
             tion,  then  mask  continuous  positive  airway  pressure   cardiac/respiratory arrest, severe encephalopathy, haemo-
             (CPAP) may be considered.                            dynamic instability, facial surgery/deformity, high risk for
                                                                  aspiration,  nonrespiratory  organ  failure,  severe  upper
             β 2 -agonists, anticholinergics and steroids form the foun-  gastrointestinal bleeding, unstable arrhythmia and upper
             dation of acute severe asthma management, but for chil-  airway obstruction. 142
             dren over 40 kg and those who have reached puberty it
             may  be  more  appropriate  to  administer  IV  adrenaline.   Intubation may be necessary when signs of deterioration
             β 2 -agonists  act  by  relaxing  bronchial  smooth  muscle,   are  present,  such  as  elevated  carbon  dioxide  levels,
             improving  mucociliary  transport  and  inhibiting  media-  exhaustion,  alteration  of  mental  status,  haemodynamic
             tor  release.  In  severe  to  life-threatening  asthma,  nebu-  instability and refractory hypoxaemia. 142  Because of high
             lised  salbutamol  is  preferred. 134   Inhaled  salbutamol   airway  pressures,  a  cuffed  endotracheal  tube  should
             combined with magnesium sulfate improves pulmonary   be used.
             function. 135   Adverse  effects  of  β 2 -agonists’  administra-  Children with acute asthma may have a raised metabolic
             tion  include  hypokalaemia,  tachycardia,  tremors,  agita-  rate and increased insensible losses, together with reduced
             tion  and  hyperglycaemia.  Mild  lactic  acidosis  may  also   oral intake. With increased intrathoracic pressure due to
             occur.  Intravenous  salbutamol  infusion  should  be  con-  air  trapping,  even  mild  dehydration  may  compromise
             sidered  when  there  is  severe,  life-threatening  asthma   cardiac output. Therefore, adequate fluid replacement is
             refractory to inhaled treatment. Inhaled salbutamol may   necessary. In addition, pulmonary secretions will thicken
             be discontinued once IV infusion has commenced, but   and plug the airways if fluid intake is inadequate. Main-
             should be reestablished before ceasing the infusion. In   tenance fluids should be provided until the child’s con-
             acute severe episodes, salbutamol is usually given every   dition and oral intake improve. 143
             20 minutes; if there is little response, continuous nebu-
             liser therapy may be required. In this instance, a feeding
             tube  is  inserted  into  the  nebuliser  and  the  chamber   NURSING THE VENTILATED CHILD
             replenished as it empties. Anticholinergics, in combina-  Principles  of  mechanical  ventilation  were  covered  in
             tion  with  β 2 -agonists,  improve  lung  function  by  aug-  Chapter  15.  Issues  such  as  gastric  decompression,  ade-
             menting  the  action  of  β 2 -agonists,  blocking  irritant   quate  analgesia  and  sedation  and  undertaking  steps  to
             receptors and bronchodilation of larger airways. 136  prevent  accidental  extubation  are  similar  to  those  for
             Corticosteroids decrease airway inflammation, enhancing   adults. Specific considerations for ventilating infants and
             the  β 2 -agonists’  effects,  and  reduce  mucus  production.   children include:
             Oral  and  intravenous  methods  of  administration  are   l  Most children are oxygenated before, during and after
             similarly efficacious. The effects of systemic steroids are   suctioning with 100% O 2 . 144  The child’s clinical status
             apparent  within  3–4  hours  of  administration,  with   is monitored throughout the procedure.
             maximal  benefit  achieved  within  6–12  hours.  There  is   l  Heated humidification is preferred in children as they
             little evidence to support giving inhaled steroids during   have  limited  respiratory  reserve  and  are  prone  to
             an acute episode. 137                                   airway blockage. 145,146
             Magnesium  sulphate  promotes  smo3oth  muscle  relax-  l  Endotracheal  suctioning  does  not  require  normal
                                                                                     147-149
             ation by inhibiting uptake of calcium. Intravenous mag-  saline instillations.
             nesium sulfate has demonstrated efficacy in acute severe   l  To prevent iatrogenic atelectasis, the suction catheter
             asthma and inhaled magnesium sulphate combined with     size  should  be  less  than  or  equal  to  two-thirds  the
             a β 2 -agonist results in improved pulmonary function. 135  internal diameter of the ETT. Suction pressure should
                                                                     be  limited  to  −60 mmHg  (−8  kPa)  for  infants,  and
             Aminophylline  has  shown  some  benefit  in  regards  to   up  to  −200 mmHg  (−27  kPa)  for  adolescents.  A
             improved  lung  function  in  severe  asthma  that  is   suction regulator is useful to monitor the amount of
   711   712   713   714   715   716   717   718   719   720   721